Lower riskDrug recall · FDA · Published August 17, 2021
RemedyRepack Carvedilol 25mg Bottles Contain Extra Paroxetine Tablets
RemedyRepack Inc. recalls 180-count Carvedilol 25mg bottles (Rx only) that accidentally contain Paroxetine tablets due to repackaging error. This could cause unintended medication interactions.
“RemedyRepack Carvedilol 25mg Bottles Contain Extra Paroxetine Tablets.” GovInfoNow, updated August 18, 2026. https://govinfonow.com/recall/35933-remedyrepack-carvedilol-25mg-bottles-contain-extra-paroxetine-tablets. Based on FDA recall #D-0754-2021 (https://api.fda.gov/drug/enforcement.json?search=recall_number:%22D-0754-2021%22&limit=1).
The FDA announced on August 17, 2021, that RemedyRepack Inc. is recalling Carvedilol 25 mg tablets due to the presence of Paroxetine Tablets, 40 mg. The agency classified this as a Class II recall.
How to tell if you have it
Brand: RemedyRepack
Product: Carvedilol 25 mg, 180-count bottle
NDC: 68382-0095-05 (Manufacturer Zydus Pharm) and 70518-1826-01 (Repackager)
Lot #: B1273286-071521
Expiration: 07/31/2022
Quantity: 4 bottles
Distribution: Two medical facilities in VA and FL
The hazard
A 500 count bottle of Carvedilol 25 mg tablets contained two Paroxetine Tablets, 40 mg. The product was repackaged into 180 count bottles.
Context
GovInfoNow's records show RemedyRePack Inc. has 35 other recalls on record since February 18, 2015. Other recent recalls of similar products include RemedyRepack Clindamycin Capsules Recall (March 24, 2025), RemedyRepack Carvedilol Tablets Recall (January 24, 2025), and Granules Pharmaceuticals Trazodone 50mg Recall (January 26, 2026).
How to tell if you have this one
Check for the 180-count bottle labeled 'Carvedilol 25 mg, Rx only' with NDC 68382-0095-05. The product was repackaged by RemedyRepack Inc. in Indiana, PA.
Brand
RemedyRepack
Category
Drug
Based on the official FDA remedy
What to do — step by step
Check Product Label
Look for the 180-count bottle with NDC 68382-0095-05 and the lot number B1273286-071521.
Where it went and when
Where it was distributed
Distributed in Florida and Virginia.
Listed by the agency
Not listed
FDA distribution: “Product was distributed to two medical facilities in VA and FL.” States read from FDA’s own wording; “not listed” means the notice does not name it.
States: Florida, Virginia.
Recall timeline
FDA terminated this recall 7 months after the firm started it.
1Firm started the recall
2FDA classified it Class II
3Published in FDA’s Enforcement Report
4FDA terminated the recall
Dates from the agency record only; steps without a date are left out.
The facts (hazard, remedy, dates, manufacturer) are pulled from the official FDA recall record. The plain-language summary and step-by-step checklist are written by GovInfoNow to make the official notice easier to act on — they don’t replace it.
Official source: FDA Recall #D-0754-2021 (August 17, 2021) — FDA publishes no per-recall page; this is the official machine-readable enforcement record. Search FDA recalls for D-0754-2021 to see it in context.
Plain-language summary written by qwen3:4b on August 18, 2026, from the official record above. Not reviewed by a person — if it conflicts with the FDA notice, the notice is correct. Report an error on this page.
GovInfoNow is an independent service and is not a government agency. We republish official FDA recall data; we don’t issue, amend or administer recalls.